JP Morgan Chase’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.6M Buy
1,059,864
+49,604
+5% +$1.47M ﹤0.01% 2091
2025
Q4
$31.4M Buy
1,010,260
+701,127
+227% +$19.2M ﹤0.01% 1687
2025
Q3
$6.67M Sell
309,133
-106,856
-26% -$1.93M ﹤0.01% 3111
2025
Q2
$5.82M Buy
415,989
+117,439
+39% +$1.59M ﹤0.01% 3011
2025
Q1
$4.02M Sell
298,550
-5,784
-2% -$98.5K ﹤0.01% 3347
2024
Q4
$5.83M Sell
304,334
-96,017
-24% -$2.09M ﹤0.01% 3205
2024
Q3
$9.11M Buy
400,351
+274,641
+218% +$4.49M ﹤0.01% 2686
2024
Q2
$1.64M Buy
125,710
+76,687
+156% +$1.06M ﹤0.01% 3947
2024
Q1
$858K Sell
49,023
-7,915
-14% -$153K ﹤0.01% 4459
2023
Q4
$1.24M Buy
56,938
+6,016
+12% +$95K ﹤0.01% 4191
2023
Q3
$781K Sell
50,922
-9,050
-15% -$173K ﹤0.01% 4231
2023
Q2
$1.43M Buy
59,972
+10,595
+21% +$272K ﹤0.01% 3794
2023
Q1
$1.26M Sell
49,377
-122,982
-71% -$3.94M ﹤0.01% 3877
2022
Q4
$5.03M Buy
172,359
+103,101
+149% +$2.38M ﹤0.01% 2807
2022
Q3
$1.42M Buy
69,258
+50,919
+278% +$915K ﹤0.01% 3748
2022
Q2
$213K Sell
18,339
-327
-2% -$4.39K ﹤0.01% 5050
2022
Q1
$345K Buy
18,666
+5,633
+43% +$108K ﹤0.01% 4913
2021
Q4
$258K Buy
+13,033
New +$243K ﹤0.01% 5213
2021
Q2
Sell
-10
Closed 6650
2021
Q1
$0 Buy
+10
New +$187 ﹤0.01% 6391
2020
Q4
Sell
-21,290
Closed -$255K 5967
2020
Q3
$255K Hold
21,290
﹤0.01% 4261
2020
Q2
$354K Hold
21,290
﹤0.01% 4003
2020
Q1
$142K Hold
21,290
﹤0.01% 4406
2019
Q4
$153K Hold
21,290
﹤0.01% 4772
2019
Q3
$233K Sell
21,290
-2,660
-11% -$58.8K ﹤0.01% 4565
2019
Q2
$794K Buy
23,950
+2,238
+10% +$89.8K ﹤0.01% 3993
2019
Q1
$909K Sell
21,712
-4,429
-17% -$200K ﹤0.01% 3864
2018
Q4
$1.19M Buy
26,141
+1,944
+8% +$112K ﹤0.01% 3633
2018
Q3
$2.03M Buy
24,197
+476
+2% +$44.9K ﹤0.01% 3455
2018
Q2
$2.28M Buy
23,721
+1,881
+9% +$199K ﹤0.01% 3316
2018
Q1
$2.3M Sell
21,840
-63
-0.3% -$6.84K ﹤0.01% 3170
2017
Q4
$3.43M Buy
21,903
+613
+3% +$78.1K ﹤0.01% 2974
2017
Q3
$2.82M Buy
+21,290
New +$3.58M ﹤0.01% 2952

Other funds holding VRDN